Other immune checkpoints, notably co-inhibitory receptors such as CTLA-4 and PD-1, initially identified in T lymphocytes, have ligands for a variety of tumor-expressed molecules that induce an immunosuppressive response. The gene discussed is PDCD1; the disease is neoplasm.